signal/raiseTrack rounds

C

Catalio Capital Management

Focus: Healthtech & bio

Catalio Capital Management took part in 4 of the startup funding rounds we tracked in 2026, leading or co-leading 1 worth $311m. By money raised, its biggest sector was Healthtech & bio. The largest was AdvanCell's $315m Series D+ round. The most recent was Star Therapeutics's Series D+ round in October 2026.

Deployed as lead$311m

Rounds led1

Rounds joined4

Largest round$315m

Rounds led (1)

EnvedaSeries D+ · Healthtech & bio · Boulder · 23 Sep$311m

Also invested (3)

Star TherapeuticsSeries D+ · Healthtech & bio · South San Francisco · 23 Oct$200m Basecamp ResearchSeries C · Healthtech & bio · London · 23 Sep$140m AdvanCellSeries D+ · Healthtech & bio · Brisbane · 15 Jul$315m

By sector

Healthtech & bio$966m

By stage

Series C$140m Series D+$826m

Co-investors

T. Rowe Price2 rounds True Ventures2 rounds Janus Henderson Investors1 round RA Capital Management1 round Durable Capital Partners1 round ICONIQ1 round Lightspeed Venture Partners1 round Baillie Gifford1 round Premji Invest1 round Kinnevik1 round